Drug Database
BI

Bioadhesive Delivery System (Advantage 24)

✓ Approved

Juniper Pharmaceuticals Inc · 治疗药物

什么是 Bioadhesive Delivery System?

Bioadhesive Delivery System 是一种治疗药物,由Juniper Pharmaceuticals Inc研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)、Sublingual (SL)/Oral Transmucosal、Topical。

药物档案

商品名Advantage 24
公司Juniper Pharmaceuticals Inc
给药途径Oral (PO), Sublingual (SL)/Oral Transmucosal, Topical
状态Approved

治疗适应症

Bioadhesive Delivery System 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Surgical and medical proceduresOral appliance application✓ Approved

相关研究文献

PubMedNature nanotechnology2026-11-19

An extracellular contractile injection system for receptor-mediated protein delivery into plant cells.

Legendre Mark G MG, Muchenje Kimberley T KT, Heredia Andrés A, Colee Clair C et al.

Protein delivery into plant cells remains a major barrier in plant biotechnology. The Photorhabdus virulence cassette (PVC) is an extracellular contractile injection system, a phage tail-like bacterial nanomachine that naturally delivers proteins into insect host cells. Here we retargeted PVCs to plants by engineering their tail fibres to recognize the plant cell surface receptor FLAGELLIN SENSITIVE 2 (FLS2). We designed and characterized a library of FLS2-targeting PVCs and evaluated their ability to deliver native and non-native cargoes, including a fluorescent protein, Cre recombinase and R2 retroelement genome editor. Engineered PVCs delivered Cre into wild-type Arabidopsis thaliana and Nicotiana benthamiana protoplasts and leaf cells with efficiencies up to 16%. Delivery was FLS2 dependent and scaled with receptor abundance, reaching 75% of leaf cells in FLS2-overexpressing Arabidopsis. We further demonstrated the PVC-mediated delivery of R2 protein, resulting in the targeted insertion of a reporter gene into the plant genome and the expression of the integrated gene. This work establishes PVCs as a platform for receptor-mediated protein delivery into plant cells, laying the foundation for targeted and precise plant genetic engineering.

PMID 43052465
阅读全文 →
PubMedJournal of translational medicine2026-11-19

In vitro biological evaluation of a water-soluble hyperbranched β-cyclodextrin nanocarrier for co-delivery of doxorubicin and curcumin.

Samadzadeh Meisam M, Salmanifard Ardestani Mohammad Taha MT, Zarepour Atefeh A, Khosravi Arezoo A et al.

Conventional chemotherapy is often limited by poor aqueous solubility, systemic toxicity, and low bioavailability. To address these limitations, a water-dispersible hyperbranched β-cyclodextrin (HBCD) crosslinked with 1,2,3,4-butanetetracarboxylic acid (BTCA) was developed as a nanocarrier for the co-delivery of doxorubicin (DOX) and curcumin (CUR). HBCD was synthesized under optimized conditions and characterized using complementary physicochemical techniques. DOX and CUR were loaded individually and in combination, and drug release kinetics were evaluated. Biological performance was assessed by hemolysis, cytocompatibility, cellular uptake assessment, apoptosis analyses, anticancer activity, and concentration-dependent drug interaction analysis using SynergyFinder+. The optimized HBCD exhibited favorable physicochemical properties and excellent water solubility. Encapsulation efficiencies in the co-loaded formulation reached 50.8% for DOX and 45.7% for CUR. Drug release showed an initial burst followed by sustained release over 96 h, with kinetics best described by the Korsmeyer-Peppas model. HBCD demonstrated excellent hemocompatibility (<2% hemolysis) and high cytocompatibility toward HDF cells. Drug-loaded formulations produced concentration-dependent cytotoxicity in cancer cell lines. Cellular association and apoptosis analyses confirmed the biological activity of the formulations, while SynergyFinder+ indicated predominantly additive drug interactions with localized concentration-dependent positive interaction regions rather than uniform synergism. BTCA-crosslinked water-dispersible HBCD provides an effective platform for the co-delivery of hydrophilic and hydrophobic anticancer agents, combining efficient drug loading, sustained release, hemocompatibility, and encouraging in vitro biological performance. These findings establish a foundation for future mechanistic, pharmacokinetic, and in vivo studies to further evaluate the translational potential of this delivery system.

PMID 43053162
阅读全文 →
PubMedJournal of religion and health2026-11-19

Pope Leo XIV: The First American Pope and the Practice of Medicine.

Lauzier David C DC

As papal elections provide the Church with an opportunity to renew itself, lessons from this renewal can extend beyond the Church, providing insights that can be applied in other areas such as healthcare. In the early stages of Pope Leo XIV's papacy, several key themes have emerged, many of which relate to issues encountered by the healthcare system in the United States. The key themes of humanity in healthcare, reconciliation, doctrinal firmness, and caring for the marginalized as lessons from Leo XIV to translate to the healthcare setting are presented in this work. These address the challenges of AI in medicine, recognizing the past missteps of organized medicine, having clear and credible medical guidelines, and prioritizing healthcare delivery to the underserved. In this work, thematic analysis and theological reflection are employed to connect the themes of Leo XIV's papacy to pressing challenges in the healthcare setting.

PMID 43052599
阅读全文 →
PubMedInternational journal of obesity (2005)2026-11-19

What is the association between mode of delivery at birth and childhood adiposity? Findings from the Southampton Women's Survey.

Crozier Sarah S, Galani Sevasti S, Barton Sheila J SJ, Harvey Nicholas C NC et al.

Childhood obesity is a major public health concern. Caesarean section (CS) delivery has been linked to increased childhood adiposity; however, the literature is inconsistent. To examine the associations between mode of delivery at birth and adiposity in childhood and whether they differ by type of CS (planned versus emergency). The Southampton Women's Survey recruited 12,583 non-pregnant women between 1998 and 2002 in Southampton, UK. From 3153 women who had liveborn singleton infants followed up after birth, mode of delivery was recorded and adiposity measured at age 4, 6-7 and 8-9 years. Outcome measures were child body mass index (BMI) and fat mass and body fat percentage measured by Dual-Energy X-ray Absorptiometry. Associations were investigated using mixed-effects linear regression models after multiple imputation by chained equations, adjusting for maternal (adiposity, age, education, pre-eclampsia, gestational diabetes, smoking during pregnancy) and child-related confounders (birthweight, sex, gestational age), ascertained using a Directed Acyclic Graph. 16% of the women had an emergency CS, and 8% a planned CS. Adjusted analyses showed that CS (versus vaginal delivery) was associated with increased offspring adiposity, with the magnitude of association increasing with the age of the child. For example, compared to children born vaginally, those born via CS had an average fat mass percentage 0.09 standard deviations (95% CI 0.00, 0.18, p = 0.04) higher and showed a 0.03 standard deviation (95% CI 0.01, 0.06; p = 0.009) greater increase in body fat percentage per year. Emergency CS was associated with increased adiposity compared to assisted vaginal delivery, particularly for BMI and fat mass outcomes. CS-delivered babies had higher childhood BMI, fat mass and body fat percentage. Emergency CS accounted for most CS deliveries and was associated with increased adiposity. The findings support important effects of maternal and early life factors on long-term health outcomes.

PMID 43052426
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Non-Canonical Peptide Self-Assembly for Mitochondria-Specific Cargo Delivery.

Jia Ziyu Z, Wen Jian J, Zhang Shengyi S, Ding Yinghao Y et al.

Targeting mitochondria is a promising strategy for precision tumor therapy, yet ligand-free mitochondrial drug delivery remains challenging. Here, we report a minimalist, intrinsically mitochondria-targeting noncanonical tetrapeptide, X-GNNpY, comprising one glycine, two (S)-2-amino-3-(naphthalen-1-yl)-propanoic acid residues (N), and one phosphorylated tyrosine (pY). Without external targeting ligands, X-GNNpY selectively accumulates in tumor-cell mitochondria through enzyme-instructed self-assembly. Conjugating chlorambucil (CLB) yields CLB-GNNpY, which efficiently redirects CLB to mitochondria. CLB-GNNpY exhibits good cellular selectivity, induces mitochondrial stress and immunogenic cell death, promotes M1-like macrophage polarization, and markedly enhances antitumor phagocytosis. This proof-of-concept study establishes noncanonical peptide self-assembly as a ligand-free supramolecular strategy for mitochondrial drug delivery and immune modulation in tumor therapy.

PMID 43053355
阅读全文 →
PubMedBMC medicine2026-11-19

Treated and untreated maternal asthma and early pregnancy outcomes: a retrospective cohort study of 324,238 infants.

Shakhshir Lama A LA, Pell Jill P JP, Hastie Claire E CE, Nelson Scott M SM et al.

Continued use of asthma medication during pregnancy is recommended, because asthma exacerbations often increase during pregnancy, and poor control may adversely affect maternal and foetal health. However, evidence on whether adverse outcomes arise from the treatment itself or just the underlying disease remains inconsistent. This study examined the relationship between maternal asthma, and its medication, and early pregnancy outcomes. A retrospective birth cohort was constructed using population-wide linked Welsh health records of 324,238 infants born between 2009 and 2022. Logistic regression was used to investigate associations between maternal asthma (treated, untreated, and medication exposure) and pregnancy outcomes: stillbirth, iatrogenic and spontaneous preterm delivery, small/very small for gestational age (SGA/VSGA), and low Apgar score. Of the 324,238 infants, 39,040 (12.0%) had mothers with asthma: 20,840 (6.4%) had treated asthma, 8,230 (2.5%) had untreated asthma, and 9,970 (3.1%) were prescribed asthma medications without recorded asthma diagnoses. Compared to offspring of mothers with no maternal asthma (reference group), those whose mothers had treated asthma had higher odds of SGA (aOR 1.13, 95% CI 1.07-1.19), VSGA (aOR 1.14, 95% CI 1.03-1.26), Apgar score < 7 (aOR 1.14, 95% CI 1.01-1.29), and iatrogenic preterm delivery (aOR 1.13, 95% CI 1.01-1.26). Associations were observed across multiple classes of asthma medication with stronger associations among the offspring of mothers prescribed more than one medication class and those with add-on therapies including long-acting muscarinic antagonists, short-acting muscarinic antagonists, leukotrienes antagonist and theophylline, consistent with more severe, or poorly controlled, asthma rather than medication effects. Untreated asthma was associated with higher risk of iatrogenic preterm delivery, and treated asthma was associated with lower risk of spontaneous preterm delivery (aOR 0.81, 95% CI 0.73-0.89). No associations were observed with stillbirth. The non-specific associations observed across different classes of asthma medication and dose-relationships with polytherapy suggested confounding by indication and severity. The findings for iatrogenic preterm delivery further supported an effect of the underlying disease rather than its treatment. These findings, together with the lower risk of spontaneous preterm delivery among treated mothers, support guideline recommendations to continue asthma treatment during pregnancy.

PMID 43053014
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Bioadhesive Delivery System